Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Oct 15, 2021 10:53am
158 Views
Post# 34009619

RE:TheraPharmaceuticals > Theratechnologies

RE:TheraPharmaceuticals > Theratechnologies If I were king of the world, I would definitely rebrand TH. The current brand has been badly tarnished and they need a new start.  I would not even have Thera in the new name. I would actually sell the name Thera Technologies as I see just tons of consumer product advertising for Thera this and Thera that, so there would likely be demand for it. I would also do a reverse split of the stock to get it permanently out of the low price zone it has been for years. I would also engage with the top end of Wall Street and make them rich via the TNSH spin-off and other deals, because they would then let TH into the game and give it a valuation like they are giving so many other stocks.

It is well past time to take some bold actions. And if cancer looks pretty good in their internal reports, this would be a great time to get started on such bold actions. Tell the world this is a new TH and then let the enthusiasm for cancer's prospects take over. 

My suggestion for the new company name: Rusty Therapeutics!

OK, maybe they should keep looking for a better alternative as perhaps that does not convey what I am looking for them to convey!

Dcutter101 wrote: How about a rebranding of sorts,..?!?


<< Previous
Bullboard Posts
Next >>